Hyperglycaemia enhances nitric oxide production in diabetes: A study from South Indian patients

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Adela, Ramu ^a   Nethi, Susheel Kumar ^a   Bagul, Pankaj K ^a   Barui, Ayan K ^a   Mattapally, Saidulu ^a   Kuncha, Madhusudan ^a   Patra, Chitta R ^a   Reddy, P Naveen Chander ^b   Banerjee, Sanjay K ^a,c  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b Mediciti Hospitals   (India)

^c TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; ENDOTHELIUM CELL; ENOS GENE; FEMALE; GAPDH GENE; GENE EXPRESSION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERTENSION; INDIA; INOS GENE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIOSYNTHESIS; BLOOD; COMPLICATION; DIET RESTRICTION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PATHOLOGY; SPRAGUE DAWLEY RAT; TRANSCRIPTION INITIATION; UMBILICAL VEIN ENDOTHELIAL CELL;

RATTUS;

ADULT; AGED; ANIMALS; BLOOD GLUCOSE; CORONARY ARTERY DISEASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPERGLYCEMIA; INDIA; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTIONAL ACTIVATION;

EID: 84929094051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125270     Document Type: Article

References (54)

1. American Heart Association-Metabolic Syndrome (2011) Available: http://www.heart.org/HEARTORG/Conditions/More/MetabolicSyndrome/About-Metabolic-Syndrome-UCM-301920-Article.jsp
2. Guariguataa L, Whitingb DR, Hambletonc I, Beagleya J, Linnenkampa U, et al. (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pr 103: 137-149. doi: 10.1016/j.diabres.2013.11.002 PMID: 24630390
3. Haridoss M, Viswanathan M, Mohan D, Subash B Vivekanandhan A (2014) Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease. Cardiovasc Diabetol 13(1): 2-8. doi: 10.1186/1475-2840-13-1 PMID: 24383855
4. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35(1):564-571.
5. Michael JF (2008) Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes 26:277-82.
6. Angelo A, Mattia A, Lisa M, Saulade K, Gian PF (2011) Endothelial dysfunction in diabetes the role of reparatory mechanisms. Diabetes Care 34 (2) S285-290.
7. Lerman A, Burnett JC (1992) Intact and altered endothelium in regulation of vasomotion. Circulation 86 (3): 12-19.
8. Shiekh GA, Taha A, Saquib NK, Rubiya D, Khurshid IA (2011) Reduced nitrate level in individuals with hypertension and diabetes. J Cardiovasc Dis Res 2: 172-176. doi: 10.4103/0975-3583.85264 PMID: 22022145
9. Lucilla DM, Cristina B, Lorena C, Elena G, Carlo B et al. (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52(5) 1270-1275. PMID: 12716763
10. Paolo T, Diego C, Alessandra C, Monica V, Anna C, et al. (2010) Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59: 2152-2159. doi: 10.2337/db09-1772 PMID: 20484137
11. Pal P, Joseph SB, Lucas L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 (1): 315-424. PMID: 17237348
12. Galen MP (1998) Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060. PMID: 9576113
13. Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, et al. (2001) Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects Relationship to microvascular complications. Journal of Diabetes and Its Complications 15: 135-143. PMID: 11358682
14. Tessari P, Cecchet D, Cosma A, Vettore M, Coracina A, et al. (2010) Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59:2152-2159. doi: 10.2337/db09-1772 PMID: 20484137
15. Patra CR, Kim JH, Pramanik K, Livius VD, Patra S, et al. (2011) Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano Lett 11(11):4932-4938. doi: 10.1021/nl2028766 PMID: 21967244
16. Barui AK, Veeriah V, Mukherjee S, Manna J, Patel AK, et al. (2012) Zinc oxide nanoflowers make new blood vessels. Nanoscale 4:7861-7869. doi: 10.1039/c2nr32369a PMID: 23152079
17. Kwok W, Lee SH, Culberson C, Korneszczuk K, Clemens MG (2009) Caveolin-1 mediates endotoxin inhibition of endothelin-1-induced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells. Am J PhysiolGastrointest Liver Physiol. 297(5): G930-939.
18. Padiya R, Choudhury D, Pal Bhadra M, Banerjee SK (2014) Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/NRF2-Keap1 pathway in fructose-fed diabetic rat. PLoS ONE 9(5): e94228. doi: 10.1371/journal.pone.0094228 PMID: 24796753
19. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y et al. (1998) Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70(13): 2446-2453. PMID: 9666719
20. Cosentino F, Hishikawa K, Katusic ZS, Lusher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96(1): 25-28. PMID: 9236411
21. Cai S, Khoo J, Channon KM (2005) Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovascular Research 65: 823-831. PMID: 15721862
22. Yang P, Cao Y, Hua LI (2010) Hyperglycemia induces iNOS gene expression and consequent nitrosative stress via JNK activation. Am J Obstet Gynecol. 203(2): 185-185. doi: 10.1016/j.ajog.2010.05.003 PMID: 20541731
23. Zhang X, Fu Y, Xu X, Li M, Du L, Han Y, Ge Y (2014) PERK pathway are involved in NO-induced apoptosis in endothelial cells cocultured with RPE under high glucose conditions. Nitric Oxide. 40C:10-16.
24. Francesco C, Keiichi H, Zvonimir SK (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25-28. PMID: 9236411
25. Naohito I, Kaushik PP, Pascale HL, Traci T, Ka B, et al. (2001) Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 12:1630-1639. PMID: 11461935
26. Chien WY, Yang KD, Eng HL, Hu YH, Lee PY, et al. (2005) Increased plasma concentration of nitric oxide in type 2 diabetes but not in non diabetic individuals with insulin resistance. Diabetes Metab 31:63-68. PMID: 15803115
27. Katsuyuki M, Shigeru N, Mariko HST, Hanae M, Tomohiko I, et al. (2001) Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects Relationship to microvascular complications. J Diabetes Complicat 15: 135-143. PMID: 11358682
28. Amrita G, Mingma LS, Yazum B, Ranabir P, Sanjay D (2011) Serum nitric oxide status in patients with type 2 diabetes in Sikkim. Int J Appl Basic Med Res 1(1): 31-35. doi: 10.4103/2229-516X.81977 PMID: 23776769
29. Das L, Mishra A, Mahdi AA, Singh AS (2014) Effect of smoke and non-smoke tobacco on nitric oxide levels in diabetic patients.J Transl Intern Med 2:36-39.
30. Zangeneh F, Arora PS, Dyck PJ, Bekris L, Lernmark A, et al. (2006) Effects of duration of type 2 diabetes mellitus on insulin secretion. EndocrPract. 12(4):388-393.
31. Fajans SS (1990) Scope and heterogeneous nature of MODY. Diabetes Care. 13(1):49-64. PMID: 2404717
32. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M (1997) Reduced Plasma Concentrations of Nitrogen Oxide in Individuals With Essential Hypertension. Hypertension. 30:405-408. PMID: 9314424
33. Camilletti A, Moretti N, Giacchetti G, Faloia E, Martarelli D, et al. (2001) Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. American Journal of Hypertension. 14(4): 382-386. PMID: 11336186
34. Higashino H, Miya H, Mukai H, Miya Y (2007) Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls. Clin Exp Pharmacol Physiol. 34(8):725-31. PMID: 17600548
35. Donmez G, Derici U, Erbas D, Arinsoy T, Onk A, Sindel S, et al. (2002)The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension. Jpn J Physiol. 52(5):435-40. PMID: 12533248
36. Chandra M, Maurya D.R, Kumar S, Basara H, Ghatak A, et al. (2003) Reversible suppression of nitric oxide system in essential hypertension. Indian Journal of Clinical Biochemistry 18 (2) 150-153. doi: 10.1007/BF02867381 PMID: 23105406
37. Mason RP, Jacob RF, Kubant R, Jacoby A, Louka F, et al. (2012) Effects of angiotensin receptor blockers on endothelial nitric oxide release: the role of eNOS variants. Br J Clin Pharmacol. 74(1):141-6. doi: 10.1111/j.1365-2125.2012.04189.x PMID: 22283728
38. Dominiczak AF, Bohr DF (1995) Nitric oxide and its putative role in hypertension. Hypertension 25: 1207-1208.
39. Hoshiyama M, Li B, Yao J, Harada T, Morioka T, Oite T (2003) Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp Nephrol. 95(2):e62-68. PMID: 14610325
40. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, et al. (1995) Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 26: 854-857. PMID: 7490139
41. Tschudi MR, Mesaros S, Luscher TF, Malinski T (1996) Direct in situ measurement of nitric oxide in mesenteric resistance arteries: Increased decomposition by superoxide in hypertension. Hypertension 27:32-35. PMID: 8591884
42. Sagar S, Kallo IJ, Nalini K, Ganguly NK, Sharma BK (1992) Oxygen free radicals in essential hypertension. Mol Cell Biochem 111:103-108. PMID: 1588931
43. Ayub SG, Ayub T, Khan SN, Dar R, Andrabi KI (2011) Reduced nitrate level in individuals with hypertension and diabetes. J Cardiovasc Dis Res 2: 172-176. doi: 10.4103/0975-3583.85264 PMID: 22022145
44. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S (2009) Endothelial dysfunction as a target for prevention of cardiovascular disease. Diab Care 32(2): S314-321.
45. Kassab A, Piwowar A (2012) Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes. Biochimie 94(9):1837-1848. doi: 10.1016/j.biochi.2012.01.020 PMID: 22333037
46. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108:1341-1348. PMID: 11696579
47. Kemeny SF, Figueroa DS, Clyne AM (2013) Hypo- and Hyperglycemia impair endothelial cell actin alignment and nitric oxide synthase activation in response to shear stress. Plos One 8(6):1-11.
48. Zhang X, Fu Y, Xu X, Li M, Du L et al. (2014) PERK pathway are involved in NO-induced apoptosis in endothelial cells cocultured with RPE under high glucose conditions. Nitric Oxide. 40C:10-16.
49. Liu XJ, Zhang ZD, Ma XC (2013) High glucose enhances LPS-stimulated human PMVEC hyperpermeability via the NO pathway. Exp Ther Med. 6(2):361-367. PMID: 24137189
50. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, et al. (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282: E386-E394. PMID: 11788371
51. Tanaka J, Qiang L, Banks AS, Welch CL, Matsumoto M, et al. (2009) Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes 58:2344-2354. doi: 10.2337/db09-0167 PMID: 19584310
52. Pietroa ND, Tomoa PD, Silvestrea SD, Giardinelli A, Pipino C, et al. (2013) Increased iNOS activity in vascular smooth muscle cells from diabetic rats: Potential role of Ca2/calmodulin-dependent protein kinase II delta 2 (CaMKIId2). Atherosclerosis 226:88-94. doi: 10.1016/j.atherosclerosis.2012.10.062 PMID: 23177014
53. Fujimoto M, Shimizu N, Kunii K, Martyn JAJ, Ueki K, et al. (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signalling in the liver of obese diabetic mice. Diabetes 54(5): 1340-1348. PMID: 15855318
54. Aktug H, Cetintas VB, Kosova B, Oltulu F, Demiray SB, et al. (2012) Dysregulation of nitric oxide synthase activity and Bcl-2 and caspase-3 gene expressions in renal tissue of streptozotocin-induced diabetic rats. Turk J Med Sci 42 (5): 830-838.